Gastroenterology and Liver

Regenerative Medicine in Liver & GI Disorders

Regenerative medicine is transforming gastroenterology and hepatology by offering novel therapeutic options for conditions previously considered irreversible. This session focuses on the application of stem cell therapy, gene editing, and tissue engineering in liver and gastrointestinal disorders. Participants will explore preclinical and clinical studies demonstrating the potential of regenerative approaches to restore tissue function, reduce fibrosis, and promote organ repair. Advances in cellular therapy, biomaterials, and organoid models will be discussed, providing insights into the translation of experimental research into clinical practice.

The track also emphasizes personalized regenerative strategies, highlighting how patient-specific therapies can optimize outcomes and minimize complications. Ethical considerations, regulatory frameworks, and safety challenges associated with regenerative interventions will be addressed. Attendees will engage in discussions on combining regenerative medicine with conventional treatments, evaluating clinical efficacy, and designing research studies that accelerate innovation. This session is intended for researchers, clinicians, and healthcare professionals who wish to contribute to the evolving field of regenerative gastroenterology and hepatology.